Visioneering Technologies has announced the completed three-year results of PROTECT, a prospective, double-masked, multinational randomised control trial which shows evidence across both cycloplegic refraction
Heidelberg Engineering and RetinAI (Ikerian AG) have announced that their product RetinAI Discovery for Clinics will soon be available through Heidelberg Engineering’s direct global
Specsavers is recognising the contribution store teams make to patient care, with a series of events, resources and surprises for support office and store
ZEISS Vision Care has launched ZEISS MyoActive, a new myopia management spectacle lens designed to slow myopia progression in children.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
